National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

Adriamycin RDF (AY-dree-uh-MY-sin …)

 A drug that is used to treat many types of cancer and is being studied in the treatment of other types of cancer. Adriamycin RDF comes from the bacterium Streptomyces peucetius. It damages DNA and may kill cancer cells. It is a type of anthracycline antitumor antibiotic. Also called Adriamycin PFS, doxorubicin, doxorubicin hydrochloride, hydroxydaunorubicin, and Rubex.



Previous Definitions:adrenocortical cancer, adrenocortical carcinoma, adrenocorticotropic hormone, AdreView, Adriamycin PFS
Next Definitions:adult T-cell leukemia/lymphoma, advance directive, advanced cancer, advanced malignant mesothelioma, adverse effect

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov